Infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) is a new
disease entity. The rate of IE after TAVI is similar to that after surgical aortic valve …

Infective endocarditis (IE) represents one of the most challenging clinical entities, requiring a
multidisciplinary approach. The increasing number of surgical and transcatheter heart …

Background: Infective endocarditis (IE) is a feared complication after surgical aortic valve
replacement (SAVR)/transcatheter aortic valve implantation (TAVI). It is not certain which …

Background: No data exist about the characteristics of infective endocarditis (IE) post-
transcatheter aortic valve replacement (TAVR) according to transcatheter valve type. We …

Background Cephalosporins are recommended for prophylaxis before transcatheter aortic
valve replacement (TAVR). Infective endocarditis (IE) after TAVR is caused by enterococci in …

Background Infective endocarditis (IE) following transcatheter aortic valve replacement
(TAVR) has been associated with a dismal prognosis. However, scarce data exist on IE …

Infective endocarditis complicating transcatheter aortic valve implantation (TAVI-IE) is a
relatively rare condition with an incidence of 0.2%–3.1% at 1 year post implant. It is …

Infective endocarditis is one of the leading life-threatening infections around the world. With
the exponential growth in the field of transcatheter interventions and advances in …

Background Stroke is one of the most common and potentially disabling complications of
infective endocarditis (IE). However, scarce data exist about stroke complicating IE after …

Although initially conceived for high-risk patients who are ineligible for surgical aortic valve
replacement (SAVR), transcatheter aortic valve replacement (TAVR) is now recommended …